EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51

Vanessa Buffa iD, Fabian H Knaup, Tim Heymann, Margherita Springer, Mathias V Schmidt, Felix Hausch iD

ACS Pharmacology & Translational Science · 10.03.2023 · 6 (3) · 361-371

DOI: 10.1021/acsptsci.2c00234 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 14.02.2023. Verfasst von Vanessa Buffa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University Darmstadt, Alarich-Weiss Straße 4, 64287 Darmstadt, Germany. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Bundesministerium f??r Bildung und Forschung.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The FK506-binding protein 51 (FKBP51) has emerged as an important regulator of the mammalian stress response and is involved in persistent pain states and metabolic pathways. The FK506 analog SAFit2 (short for selective antagonist of FKBP51 by induced fit) was the first potent and selective FKBP51 ligand with an acceptable pharmacokinetic profile. At present, SAFit2 represents the gold standard for FKBP51 pharmacology and has been extensively used in numerous biological studies. Here we review the current knowledge on SAFit2 as well as guidelines for its use.

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University Darmstadt, Alarich-Weiss Straße 4, 64287 Darmstadt, Germany.
  • Research Group Neurobiology of Stress Resilience, Max Planck Institute of Psychiatry, 80804 Munich, Germany.

ORCID-Profile: Vanessa Buffa, Felix Hausch

Förderung

  • Bundesministerium f??r Bildung und Forschung

Zitieren

APA

Buffa, V., Knaup, F. H., Heymann, T., Springer, M., Schmidt, M. V., & Hausch, F. (2023). Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51. ACS Pharmacology & Translational Science, 6(3), 361-371. https://doi.org/10.1021/acsptsci.2c00234

Vancouver

Buffa V, Knaup FH, Heymann T, Springer M, Schmidt MV, Hausch F. Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51. ACS Pharmacology & Translational Science. 2023;6(3):361-371. doi:10.1021/acsptsci.2c00234

BibTeX
@article{Buffa2023,
  author = {Buffa, Vanessa and Knaup, Fabian H and Heymann, Tim and Springer, Margherita and Schmidt, Mathias V and Hausch, Felix},
  title = {Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51},
  journal = {ACS Pharmacology & Translational Science},
  year = {2023},
  volume = {6},
  number = {3},
  pages = {361--371},
  doi = {10.1021/acsptsci.2c00234}
}
Kostenlos starten →